Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2007 Jun;26(6):973-5.
doi: 10.1007/s10067-006-0219-0. Epub 2006 Mar 25.

Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis

Affiliations
Case Reports

Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis

Sawsan J Hayat et al. Clin Rheumatol. 2007 Jun.

Abstract

Because disease activity in systemic lupus erythematosus correlates well with increased serum levels and activity of the cytokine tumor necrosis factor alpha (TNF-alpha), we report on the safety and efficacy of infliximab, a chimeric monoclonal antibody directed against TNF-alpha, given to a patient with active lupus with diffuse proliferative nephritis (WHO Class IV). This patient who failed to remit with a combination of full-dose steroids, mycophenolate mofetil, and cyclosporine, went into sustained remission with the addition of infliximab infusions.

PubMed Disclaimer

References

    1. Arthritis Rheum. 2000 Nov;43(11):2381-2 - PubMed
    1. Przegl Lek. 1996;53(8):623-6 - PubMed
    1. Arch Immunol Ther Exp (Warsz). 1998;46(6):375-80 - PubMed
    1. Br J Rheumatol. 1996 Nov;35(11):1067-74 - PubMed
    1. J Rheumatol. 2003 Dec;30(12):2557-62 - PubMed

Publication types

LinkOut - more resources